Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group.
Katodritou E, Dalampira D, Delimpasi S, Ntanasis-Stathopoulos I, Karaolidou F, Gkioka AI, Labropoulou V, Spanoudakis E, Triantafyllou T, Kotsopoulou M, Michalis E, Vadikolia C, Papadopoulou T, Sevastoudi A, Michael M, Daiou A, Pentidou A, Kostopoulos I, Palaska V, Gavriatopoulou M, Kyrtsonis MC, Verrou E, Kastritis E, Dimopoulos MA, Terpos E. Katodritou E, et al. Among authors: labropoulou v. Am J Hematol. 2024 Oct;99(10):1897-1905. doi: 10.1002/ajh.27425. Epub 2024 Jul 2. Am J Hematol. 2024. PMID: 38953456
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.
Katodritou E, Terpos E, Delimpasi S, Kotsopoulou M, Michalis E, Vadikolia C, Kyrtsonis MC, Symeonidis A, Giannakoulas N, Vadikolia C, Michael M, Kalpadakis C, Gougopoulou T, Prokopiou C, Kaiafa G, Christoulas D, Gavriatopoulou M, Giannopoulou E, Labropoulou V, Verrou E, Kastritis E, Konstantinidou P, Anagnostopoulos A, Dimopoulos MA. Katodritou E, et al. Among authors: labropoulou v. Blood Cancer J. 2018 Mar 9;8(3):31. doi: 10.1038/s41408-018-0059-6. Blood Cancer J. 2018. PMID: 29523783 Free PMC article. Clinical Trial.
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study group.
Katodritou E, Kastritis E, Dalampira D, Delimpasi S, Spanoudakis E, Labropoulou V, Ntanasis-Stathopoulos I, Gkioka AI, Giannakoulas N, Kanellias N, Papadopoulou T, Sevastoudi A, Michalis E, Papathanasiou M, Kotsopoulou M, Sioni A, Triantafyllou T, Daiou A, Papadatou M, Kyrtsonis MC, Pouli A, Kostopoulos I, Verrou E, Dimopoulos MA, Terpos E. Katodritou E, et al. Among authors: labropoulou v. Am J Hematol. 2023 May;98(5):730-738. doi: 10.1002/ajh.26891. Epub 2023 Mar 16. Am J Hematol. 2023. PMID: 36869876 Free article.
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study.
Kastritis E, Terpos E, Symeonidis A, Labropoulou V, Delimpasi S, Mancuso K, Zamagni E, Katodritou E, Rivolti E, Kyrtsonis MC, Roussou M, Fotiou D, Theodorakakou F, Ntanasis-Stathopoulos I, Hatjiharissi E, Kanellias N, Migkou M, Cheliotis G, Manousou K, Gavriatopoulou M, Dimopoulos MA. Kastritis E, et al. Among authors: labropoulou v. Am J Hematol. 2023 Sep;98(9):E226-E229. doi: 10.1002/ajh.27001. Epub 2023 Jun 21. Am J Hematol. 2023. PMID: 37340832 Free article. Clinical Trial. No abstract available.
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece.
Chatzilygeroudi T, Darmani I, El Gkotmi N, Vryttia P, Douna S, Bouchla A, Labropoulou V, Kotsopoulou M, Symeonidis A, Pagoni M, Pappa V, Papageorgiou SG. Chatzilygeroudi T, et al. Among authors: labropoulou v. J Clin Med. 2024 Jan 19;13(2):584. doi: 10.3390/jcm13020584. J Clin Med. 2024. PMID: 38276092 Free PMC article.
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.
Jitaru C, Symeonidis A, Badelita S, Katodritou E, Colita A, Mpanti A, Bancos A, Tigu B, Rotariu P, Urian L, Rus I, Dima D, Bojan A, Damian M, Labropoulou V, Muresan MS, Fotiou D, Fetica B, Petrushev B, Dascalescu A, Dalampira D, Buruiana S, Constantinescu C, Zdrenghea M, Dimopoulos MA, Tomuleasa C, Terpos E. Jitaru C, et al. Among authors: labropoulou v. J Hematol. 2024 Oct;13(5):207-215. doi: 10.14740/jh1343. Epub 2024 Oct 21. J Hematol. 2024. PMID: 39493599 Free PMC article.
High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients.
Matsagos S, Verigou E, Kourakli A, Alexis S, Vrakas S, Argyropoulou C, Lazaris V, Spyropoulou P, Labropoulou V, Georgara N, Lykouresi M, Karakantza M, Alepi C, Symeonidis A. Matsagos S, et al. Among authors: labropoulou v. Front Med (Lausanne). 2022 Feb 16;9:845490. doi: 10.3389/fmed.2022.845490. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35252277 Free PMC article.
Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma.
Diamantopoulos PT, Kontandreopoulou CN, Stafylidis C, Vlachopoulou D, Smilakou S, Patsialos I, Syriopoulou S, Gkikas A, Athanasopoulos EN, Vogiatzakis A, Panousi E, Kyriakakis G, Anastasopoulou A, Mantzourani M, Labropoulou V. Diamantopoulos PT, et al. Among authors: labropoulou v. Vaccines (Basel). 2024 Oct 25;12(11):1216. doi: 10.3390/vaccines12111216. Vaccines (Basel). 2024. PMID: 39591119 Free PMC article.
Fetal hemoglobin induction in azacytidine responders enlightens methylation patterns related to blast clearance in higher-risk MDS and CMML.
Chatzilygeroudi T, Chondrou V, Boers R, Siamoglou S, Athanasopoulou K, Verigou E, Gribnau J, Alexis S, Labropoulou V, Kourakli A, Patrinos GP, Sgourou A, Symeonidis A. Chatzilygeroudi T, et al. Among authors: labropoulou v. Clin Epigenetics. 2024 Jun 15;16(1):79. doi: 10.1186/s13148-024-01687-x. Clin Epigenetics. 2024. PMID: 38879530 Free PMC article.
50 results